Xu Y - Search Results

1

Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer Patients.

Xu Y, Peng Y, Shen M, Liu L, Lei J, Gao S, Wang Y, Lan A, Li H, Liu S. Xu Y, et al. J Oncol. 2022 Apr 20;2022:1525245. doi: 10.1155/2022/1525245. eCollection 2022. J Oncol. 2022. PMID: 35498539 Free PMC article.

2

Identification of a Prognostic Risk Signature of Kidney Renal Clear Cell Carcinoma Based on Regulating the Immune Response Pathway Exploration.

Wu G, Xu Y, Han C, Wang Z, Li J, Wang Q, Che X. Wu G, et al. Among authors: xu y. J Oncol. 2020 Dec 30;2020:6657013. doi: 10.1155/2020/6657013. eCollection 2020. J Oncol. 2020. PMID: 33456463 Free PMC article.

3

Study on HOXBs of Clear Cell Renal Cell Carcinoma and Detection of New Molecular Target.

Wu G, Li X, Liu Y, Li Q, Xu Y, Wang Q. Wu G, et al. Among authors: xu y. J Oncol. 2021 Jul 8;2021:5541423. doi: 10.1155/2021/5541423. eCollection 2021. J Oncol. 2021. PMID: 34306077 Free PMC article.

4

A New Survival Model Based on ADAMTSs for Prognostic Prediction in Clear Cell Renal Cell Carcinoma.

Wu G, Li J, Xu Y, Che X, Chen F, Wang Q. Wu G, et al. Among authors: xu y. J Oncol. 2021 Sep 23;2021:2606213. doi: 10.1155/2021/2606213. eCollection 2021. J Oncol. 2021. PMID: 34603444 Free PMC article.

5

Liu L, Chen C, Tu G, Peng Y, Shen M, Xu Y, Liu S. Liu L, et al. Among authors: xu y. Front Cell Dev Biol. 2022 Mar 4;10:821727. doi: 10.3389/fcell.2022.821727. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35309942 Free PMC article.

6

Development and Validation of a Novel PPAR Signaling Pathway-Related Predictive Model to Predict Prognosis in Breast Cancer.

Xu Y, Shu D, Shen M, Wu Q, Peng Y, Liu L, Tang Z, Gao S, Wang Y, Liu S. Xu Y, et al. J Immunol Res. 2022 Jun 2;2022:9412119. doi: 10.1155/2022/9412119. eCollection 2022. J Immunol Res. 2022. PMID: 35692496 Free PMC article.

7

ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway.

Zhang P, Xu Y, Chen S, Wang Z, Zhao L, Chen C, Kang W, Han R, Qiu J, Wang Q, Gao H, Wu G, Xia Q. Zhang P, et al. Among authors: xu y. J Oncol. 2022 Jun 21;2022:2724515. doi: 10.1155/2022/2724515. eCollection 2022. J Oncol. 2022. PMID: 35774359 Free PMC article.

8

Prognostic Signature and Therapeutic Value Based on Membrane Lipid Biosynthesis-Related Genes in Breast Cancer.

Xu Y, Jin Y, Gao S, Wang Y, Qu C, Wu Y, Ding N, Dai Y, Jiang L, Liu S. Xu Y, et al. J Oncol. 2022 Aug 25;2022:7204415. doi: 10.1155/2022/7204415. eCollection 2022. J Oncol. 2022. PMID: 36059802 Free PMC article.

9

Cell Division Cycle-Associated Protein 3 (CDCA3) Is a Potential Biomarker for Clinical Prognosis and Immunotherapy in Pan-Cancer.

Xu Y, Shen M, Peng Y, Liu L, Tang L, Yang T, Pu D, Tan W, Zhang W, Liu S. Xu Y, et al. Biomed Res Int. 2022 Aug 30;2022:4632453. doi: 10.1155/2022/4632453. eCollection 2022. Biomed Res Int. 2022. Retraction in: Biomed Res Int. 2023 Jun 21;2023:9870382. doi: 10.1155/2023/9870382 PMID: 36082153 Free PMC article. Retracted. Review.

10

Cuprotosis-Related Genes: Predicting Prognosis and Immunotherapy Sensitivity in Pancreatic Cancer Patients.

Xu Y, Li H, Lan A, Wu Q, Tang Z, Shu D, Tan Z, Liu X, Liu Y, Liu S. Xu Y, et al. J Oncol. 2022 Sep 9;2022:2363043. doi: 10.1155/2022/2363043. eCollection 2022. J Oncol. 2022. PMID: 36117848 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73,589 results

Search Page

Filters